The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Adjuvant chemotherapy for resected biliary tract cancer: A retrospective analysis.
M. Lucchesi
No relevant relationships to disclose
E. Vasile
No relevant relationships to disclose
M. Lencioni
No relevant relationships to disclose
C. Caparello
No relevant relationships to disclose
S. Caponi
No relevant relationships to disclose
L. Ginocchi
No relevant relationships to disclose
U. Boggi
No relevant relationships to disclose
F. Mosca
No relevant relationships to disclose
F. Filipponi
No relevant relationships to disclose
M. Seccia
No relevant relationships to disclose
M. Chiarugi
No relevant relationships to disclose
M. Andreuccetti
No relevant relationships to disclose
S. Ricci
No relevant relationships to disclose
A. Falcone
Honoraria - Amgen; Merck Serono; Roche
Research Funding - Amgen; Merck Serono; Roche